Huang Lijia, Vanstone Megan R, Hartley Taila, Osmond Matthew, Barrowman Nick, Allanson Judith, Baker Laura, Dabir Tabib A, Dipple Katrina M, Dobyns William B, Estrella Jane, Faghfoury Hanna, Favaro Francine P, Goel Himanshu, Gregersen Pernille A, Gripp Karen W, Grix Art, Guion-Almeida Maria-Leine, Harr Margaret H, Hudson Cindy, Hunter Alasdair G W, Johnson John, Joss Shelagh K, Kimball Amy, Kini Usha, Kline Antonie D, Lauzon Julie, Lildballe Dorte L, López-González Vanesa, Martinezmoles Johanna, Meldrum Cliff, Mirzaa Ghayda M, Morel Chantal F, Morton Jenny E V, Pyle Louise C, Quintero-Rivera Fabiola, Richer Julie, Scheuerle Angela E, Schönewolf-Greulich Bitten, Shears Deborah J, Silver Josh, Smith Amanda C, Temple I Karen, van de Kamp Jiddeke M, van Dijk Fleur S, Vandersteen Anthony M, White Sue M, Zackai Elaine H, Zou Ruobing, Bulman Dennis E, Boycott Kym M, Lines Matthew A
The Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada.
Hum Mutat. 2016 Feb;37(2):148-54. doi: 10.1002/humu.22924. Epub 2015 Nov 19.
Mandibulofacial dysostosis with microcephaly (MFDM) is a multiple malformation syndrome comprising microcephaly, craniofacial anomalies, hearing loss, dysmorphic features, and, in some cases, esophageal atresia. Haploinsufficiency of a spliceosomal GTPase, U5-116 kDa/EFTUD2, is responsible. Here, we review the molecular basis of MFDM in the 69 individuals described to date, and report mutations in 38 new individuals, bringing the total number of reported individuals to 107 individuals from 94 kindreds. Pathogenic EFTUD2 variants comprise 76 distinct mutations and seven microdeletions. Among point mutations, missense substitutions are infrequent (14 out of 76; 18%) relative to stop-gain (29 out of 76; 38%), and splicing (33 out of 76; 43%) mutations. Where known, mutation origin was de novo in 48 out of 64 individuals (75%), dominantly inherited in 12 out of 64 (19%), and due to proven germline mosaicism in four out of 64 (6%). Highly penetrant clinical features include, microcephaly, first and second arch craniofacial malformations, and hearing loss; esophageal atresia is present in an estimated ∼27%. Microcephaly is virtually universal in childhood, with some adults exhibiting late "catch-up" growth and normocephaly at maturity. Occasionally reported anomalies, include vestibular and ossicular malformations, reduced mouth opening, atrophy of cerebral white matter, structural brain malformations, and epibulbar dermoid. All reported EFTUD2 mutations can be found in the EFTUD2 mutation database (http://databases.lovd.nl/shared/genes/EFTUD2).
伴有小头畸形的下颌面骨发育不全(MFDM)是一种多发性畸形综合征,包括小头畸形、颅面异常、听力丧失、畸形特征,在某些情况下还包括食管闭锁。剪接体GTP酶U5-116 kDa/EFTUD2单倍剂量不足是其病因。在此,我们回顾了迄今为止所描述的69例个体中MFDM的分子基础,并报告了38例新个体中的突变情况,使来自94个家族的报告个体总数达到107例。致病性EFTUD2变异包括76种不同的突变和7种微缺失。在点突变中,错义替换相对较少(76例中有14例;18%),而相对于获得性终止密码子(76例中有29例;38%)和剪接(76例中有33例;43%)突变。在已知的情况下,64例个体中有48例(75%)的突变起源于新发,64例中有12例(19%)为显性遗传,64例中有4例(6%)是由于已证实的生殖系嵌合体。高外显率的临床特征包括小头畸形、第一和第二鳃弓颅面畸形以及听力丧失;估计约27%的患者存在食管闭锁。小头畸形在儿童期几乎普遍存在,一些成年人在成年后表现出晚期“追赶”生长并达到正常头型。偶尔报告的异常包括前庭和听小骨畸形、张口减少、脑白质萎缩、脑结构畸形和眼球表层皮样囊肿。所有报告的EFTUD2突变都可以在EFTUD2突变数据库(http://databases.lovd.nl/shared/genes/EFTUD2)中找到。